The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 269 participants.

Also called NCT05521282

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 269 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05521282
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05521282. Randomized; single masking; primary purpose treatment. Start 2021-03-09 (actual); primary completion 2022-06-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy of Qianglidingxuan Tablets in the Treatment of Hypertension
Condition
Hypertension
Condition
Medicine, Chinese Traditional
Intervention (Drug)
Treatment group
Lead sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences (class: other)
Collaborator
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine (class: other)
Collaborator
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine (class: other)
Collaborator
Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine (class: not stated)
Collaborator
Affiliated Hospital of Changchun University of Chinese Medicine (class: other)

Record details

Record id
cardio:ct-nct05521282
Content hash
d9df5f9e4a1203ceb5bb78306031692ffbfa0f2a6ba28a3fe5d44d5d5327e23a